| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| 10,000 SPECTRUM PHARMA | 2012-12 | PURCHASE | 2023-04 | 6,431 | 113,400 | -106,969 | ||||
| 6,315 SPECTRUM PHARMA | 2011-12 | PURCHASE | 2023-04 | 4,061 | 94,535 | -90,474 | ||||
| 6,685 SPECTRUM PHARMA | 2013-12 | PURCHASE | 2023-04 | 4,299 | 58,961 | -54,662 | ||||
| 0.10300 ASSERTIO | 2013-12 | PURCHASE | 2023-08 | 1 | 5 | -4 | ||||
| 0.62800 ASSERTIO | 2018-12 | PURCHASE | 2023-08 | 3 | 37 | -34 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 3815 SHS SPECTRUM PHARMACUETICALS | ||
| 10000 SHS SPECTRUS PHARMACEUTICALS | ||
| 22467 SHS SPECTRUM PHARMACUETICALS | ||
| 96000 SHS SPECTRUM PHARMACEUTICALS | ||
| 2500 SPECTRUM PHARMACEUTICALS INC | ||
| 19930 ASSERTIO HOLDINGS INC COM | 1,141,396 | 21,325 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT OTHER PROFESSIONAL FEES | 125 |